JCN Newswire39 nóiméad
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
VELSIPITY (R) is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. Regulatory approvals have been granted in US, EU, ...